- AU$846.39m
- AU$2.46bn
- AU$3.35bn
Annual income statement for Nufarm, fiscal year end - September 30th, AUD millions except per share, conversion factor applied.
2020 July 31st | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,847 | 3,216 | 3,773 | 3,481 | 3,346 |
| Cost of Revenue | |||||
| Gross Profit | 735 | 835 | 973 | 1,021 | 786 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,062 | 3,059 | 3,565 | 3,241 | 3,283 |
| Operating Profit | -214 | 157 | 208 | 239 | 62.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -311 | 95.7 | 128 | 155 | -45.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -362 | 65.1 | 107 | 111 | -5.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -470 | 57.7 | 99.9 | 99.8 | -25.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -470 | 57.7 | 99.9 | 99.8 | -25.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.526 | 0.144 | 0.288 | 0.28 | -0.19 |
| Dividends per Share |